PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis
Author:
Publisher
Computers, Materials and Continua (Tech Science Press)
Subject
Cancer Research,Oncology,General Medicine
Reference51 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: A Cancer Journal for Clinicians,2021
2. Cancer statistics, 2020;Siegel;CA: A Cancer Journal for Clinicians,2020
3. Rethinking ovarian cancer: Recommendations for improving outcomes;Vaughan;Nature Reviews Cancer,2011
4. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients;Mozzetti;Clinical Cancer Research,2005
5. Paclitaxel and its evolving role in the management of ovarian cancer;Kampan;BioMed Research International,2015
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing;Archives of Biochemistry and Biophysics;2024-11
2. Silicon, Carbon, Germanium, Aluminum Nitride nanocages (Si60, C60, Ge60, Al30N30) as catalysts of N2 reduction to NH3;Silicon;2024-02-13
3. Advances in the role of GPX3 in ovarian cancer (Review);International Journal of Oncology;2024-01-30
4. Epigenetic Alterations as an Adaptive Response to Chemotherapy;Drug Resistance in Cancer: Mechanisms and Strategies;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3